Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)Suspended - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)Suspended - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Suspended - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)Suspended - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)Suspended - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
